Positive CHMP opinion is based on data from the DEVOTE study which evaluated the high dose regimen of nusinersen in treatment ...
Lipton and his colleagues have created a new class of deployable structures that could one day be used to create artificial ...
Scholar Rock Holding Company ( SRRK) is a Boston-based, clinical-stage biotech that was founded in 2012, focusing on ...
Pharmaceutical Technology on MSN
High-dose Spinraza inches closer to EU approval despite FDA setback
A CHMP panel has recommended the high-dose version’s approval, countering an FDA rejection for the drug in recent months.
CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative ...
Molecular diagnostics firm BillionToOne raised $314 million in the DNA test maker’s upsized initial public offering but saw ...
Discover how precision biotherapeutics can transform healthcare in India by personalizing treatments based on genetic and ...
Food - Microbial contamination - SalmonellaDistribution: OnlineAlbertaOntario Online link SOURCE Canadian Food ...
If you want a foretaste of it, you can find it in Ubeyitogullari's lab.
Novartis plans to upfit a 202,000-square-foot purpose-built space in Pathway Triangle, a new advanced manufacturing campus in ...
Biohaven (BHVN) downgraded after FDA setback for VYGLXIA. Learn key risks, pipeline shifts, and what investors should watch next. Click here to read more.
Roche’s fenebrutinib shows unprecedented positive phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback